Synlett 2008(6): 919-923  
DOI: 10.1055/s-2008-1042906
LETTER
© Georg Thieme Verlag Stuttgart · New York

Efficient Access to Isoxazoles from Alkenes

Jianping Xu, Ashton T. Hamme II*
Department of Chemistry, Jackson State University, Jackson, MS 39217-0510, USA
Fax: +1(601)9793674; e-Mail: ashton.t.hamme@jsums.edu;
Weitere Informationen

Publikationsverlauf

Received 18 December 2007
Publikationsdatum:
11. März 2008 (online)

Abstract

The direct regioselective synthesis of 3,5-disubstituted isoxazoles was achieved in one reaction vessel through a sequence of reactions involving the net bromination of an electron-deficient alkene, in situ generation of a nitrile oxide, 1,3-dipolar cycloaddition, and loss of HBr from an intermediate 5,5-disubstituted bromoisoxazoline. This one-pot process enables the synthesis of 3,5-disubstituted isoxazoles directly from electron-deficient alkenes thereby negating the isolation of the 1,1-disubstituted bromoalkene alkyne surrogate.

    References and Notes

  • 1 Talley JJ. Brown DL. Carter JS. Graneto MJ. Koboldt CM. Masferrer JL. Perkins WE. Rogers RS. Shaffer AF. Zhang YY. Zweifel BS. Seibert K. J. Med. Chem.  2000,  43:  775 
  • 2a Lee Y.-S. Kim BH. Bioorg. Med. Chem. Lett.  2002,  12:  1395 
  • 2b Srivastava S. Bajpai LK. Batra S. Bhaduri AP. Maikhuri JP. Gupta G. Dhar JD. Bioorg. Med. Chem.  1999,  7:  2607 
  • 3a Simoni D. Grisolia G. Giannini G. Roberti M. Rondanin R. Piccagli L. Baruchello R. Rossi M. Romagnoli R. Invidiata FP. Grimaudo S. Jung MK. Hamel E. Gebbia N. Crosta L. Abbadessa V. Di Cristina A. Dusonchet L. Meli M. Tolomeo M. J. Med. Chem.  2005,  48:  723 
  • 3b Kaffy J. Pontikis R. Carrez D. Croisy A. Monneret C. Florent J.-C. Bioorg. Med. Chem.  2006,  14:  4067 
  • 4a Pruitt JR. Pinto DJ. Estrella MJ. Bostrom LL. Knabb RM. Wong PC. Wright MR. Wexler RR. Bioorg. Med. Chem. Lett.  2000,  10:  685 
  • 4b Nantermet PG. Barrow JC. Lundell GF. Pellicore JM. Rittle KE. Young M. Freidinger RM. Connolly TM. Condra C. Karczewski J. Bednar RA. Gaul SL. Gould RJ. Prendergast K. Selnick HG. Bioorg. Med. Chem. Lett.  2002,  12:  319 
  • 4c Batra S. Srinivasan T. Rastogi SK. Kundu B. Patra A. Bhaduri AP. Dixit M. Bioorg. Med. Chem. Lett.  2002,  12:  1905 
  • 4d Batra S. Roy AK. Patra A. Bhaduri AP. Surin WR. Raghavan SAV. Sharma P. Kapoor K. Dikshit M. Bioorg. Med. Chem.  2004,  12:  2059 
  • 5 Jung HK. Doddareddy MR. Cha JH. Rhim H. Cho YS. Koh HY. Jung BY. Pae AN. Bioorg. Med. Chem.  2004,  12:  3965 
  • 6a Sandanayaka VP. Youjun Y. Org. Lett.  2000,  2:  3087 
  • 6b Croce PD. La Rosa C. Zecchi G. J. Chem. Soc., Perkin Trans. 1  1985,  2621 
  • 6c Easton CJ. Heath GA. Hughes CMM. Lee CKY. Savage GP. Simpson GW. Tiekink ERT. Vuckovic GJ. Webster RD. J. Chem. Soc., Perkin Trans. 1  2001,  1168 
  • 7 Dadiboyena S. Xu J. Hamme AT. Tetrahedron Lett.  2007,  48:  1295 
  • 8 Hamme AT. Xu J. Wang J. Cook T. Ellis E. Heterocycles  2005,  65:  2885 
  • 9a Houk KN. Sims J. Duke RE. Strozier RW. George JK. J. Am. Chem. Soc.  1973,  95:  7287 
  • 9b Houk KN. Sims J. Watts CR. Luskus LJ. J. Am. Chem. Soc.  1973,  95:  7301 
  • 9c Houk KN. Acc. Chem. Res.  1975,  8:  361 
  • 9d Padwa A. 1,3-Dipolar Cycloaddition Chemistry   John Wiley and Sons; New York: 1984. 
  • 10a Dunn GL. DiPasquo VJ. Hoover JRE. J. Org. Chem.  1968,  33:  1454 
  • 10b Smith AB. Branca SJ. Pilla NN. Guaciaro MA. J. Org. Chem.  1982,  47:  1855 
  • 10c Hanessian S. Mainetti E. Lecomte F. Org. Lett.  2006,  8:  4047 
  • 11 Zamponi GW. Stotz SC. Staples RJ. Andro TM. Nelson JK. Hulubei V. Blumenfeld A. Natale NR. J. Med. Chem.  2003,  46:  87 
  • 12a Pathak R. Roy AK. Kanojiya S. Batra S. Tetrahedron Lett.  2005,  46:  5289 
  • 12b Patra A. Batra S. Bhaduri AP. Khanna A. Chander R. Dikshit M. Bioorg. Med. Chem.  2003,  11:  2269 
  • 13a Sandanayaka VP. Youjun Y. Org. Lett.  2000,  2:  3087 
  • 13b Croce PD. La Rosa C. Zecchi G. J. Chem. Soc., Perkin Trans. 1  1985,  2621 
  • 14a Miyaoka H. Kajiwara Y. Hara Y. Yamada Y. J. Org. Chem.  2001,  66:  1429 
  • 14b Trost BM. Bridges AJ.
    J. Org. Chem.  1975,  40:  2014 
15

General Experimental Procedure
After the alkene (0.5 mmol) was dissolved in CH2Cl2 (15 mL), bromine (0.55 mmol) was added dropwise. After all of the alkene was completely consumed, as confirmed by TLC on silica gel (hexanes-EtOAc, 4:1), the hydroximoyl chloride (0.5 mmol) was added, and Et3N (1.2 mmol) was added shortly thereafter. The reaction mixture was stirred at r.t. until the disappearance of the bromoalkene, as verified by TLC on silica gel (hexanes-EtOAc, 4:1). The reaction mixture was washed with H2O (3 × 10 mL), and the organic layer was dried over anhyd Na2SO4. The crude products were purified by flash column chromatography over silica gel using hexanes-EtOAc (4:1) as the eluent system. This procedure provides pure isoxazole products for entries 1-15 in 58-97% yield.
Spectroscopic data for Entry 9, Table 1
Colorless solid (74 mg, 73%), mp 84-87 °C. IR (CaF2, CCl4): ν = 1696 cm-1. 1H NMR: δ = 3.89 (s, 3 H), 7.00 (d, J = 8.9 Hz, 2 H), 7.25 (s, 1 H), 7.79 (d, J = 8.9 Hz, 2 H), 10.02 (s, 1 H). 13C NMR: δ = 55.4, 106.4, 114.2 (2 C), 119.9, 128.3 (2 C), 161.5, 162.7, 165.9, 178.5. HRMS (EI): m/z calcd for C11H9NO3 [M+ + 1]: 203.0582; found: 203.0628. All spectroscopic and HRMS data were obtained for previously unreported compounds.